CCR2 and cardiomyopathy: By contrast, CCR2−/− mice were protected from cardiomyopathy (Fig. 4B), showed reduced mRNA expression of ECM genes (Fig. 4E) and cardiomyocyte hypertrophy (Fig. 4F) while still presenting kidney disease (supplemental Fig. 4B).